• 제목/요약/키워드: Patient skin dose

검색결과 146건 처리시간 0.032초

슬관절 전치환술 중 지속 정주한 Fentanyl이 압박띠로 인한 심혈관계 변화 및 수술 후 선행 진통에 미치는 효과 (Effect of Intraoperative Continuous I.V. Fentanyl on Tourniquet Induced Cardiovascular Changes and Postoperative Preemptive Analgesia in Total Knee Replacements)

  • 이종원;전종헌;김영선;정미애;심재철;김교상
    • The Korean Journal of Pain
    • /
    • 제18권2호
    • /
    • pp.165-170
    • /
    • 2005
  • Background: It is difficult to treat tourniquet-induced hypertension despite adequate anesthesia, and the mechanism of that is not known. And it may be possible that intraoperative continuous infusion of opioid induces preemptive analgesia postoperatively. We investigated the effect of intraoperative continuous i.v. fentanyl on tourniquet induced cardiovascular changes and postoperative preemptive analgesia in total knee replacements. Methods: Sixty patients were randomly assigned to two groups; In study group ($1.5{\mu}g/kg$ loading and $0.5{\mu}g/kg/hr$ continuous infusion of fentanyl before skin incision and tourniquet inflation) and control group (no treatment). Anesthesia was maintained with enflurane (1-2 MAC) and 50% nitrous oxide in oxygen. Arterial pressure and heart rate were compared between two groups. They received postoperative pain treatment with patient-controlled analgesia (PCA) with fentanyl during the postoperative 48 hours after total knee replacement. Visual analog scale (VAS) scores at either rest or movement were used to assess pain. Total fentanyl dose delivered, number of PCA requests, supplemental analgesics, overall satisfaction score and adverse events were evaluated. Results: There were no significant differences between the two groups on cardiovascular changes by tourniquet induced pain effect. VAS, PCA delivered dose and PCA demands at movement in the 24-48 hour decreased in study group compared with control group (P < 0.05). But there were no significant differences between the two groups on the other time periods except 24-48 hour's patient satisfaction and adverse events. Conclusions: We suggest that intraoperative continuous i.v. fentanyl infusion dose not affect cardiovascular change by tourniquet induced pain. But it may induce preemptive analgesia postoperatively.

Morphine과 Ketorolac의 선행진통법이 수술 후 통증, 코티졸, 산소포화도 및 심박동 수에 미치는 효과 (The Effects of Preemptive Analgesia of Morphine and Ketorolac on Postoperative Pain, Cortisol, $O_2$ Saturation and Heart Rate)

  • 서윤주;윤혜상
    • 대한간호학회지
    • /
    • 제38권5호
    • /
    • pp.720-729
    • /
    • 2008
  • Purpose: This study investigated the preemptive analgesic effects of Morphine and Ketorolac on postoperative pain, cortisol, $O_2$ saturation and heart rate for the first 24 hr after abdominal surgery. Methods: Data collection was performed from April 1 to September 30, 2006. Forty patients undergoing a gastrectomy under general anesthesia were randomly allocated to the experimental or control group. The experimental group (20 patients) was administered Morphine and Ketorolac approximately 1 hr prior to skin incision, but the control group (20 patients) was administered Morphine and Ketorolac at peritoneum closure through a patient-controlled analgesia (PCA) pump. Postoperative pain, blood pressure, heart rate, cortisol, $O_2$ saturation, frequency of the PCA button pressed and doses of additional analgesics were observed through post operative 24 hr. Collected data was analyzed using t-test, $X^2$ test, repeated measures ANOVA, and Bonferroni methods. Results: Postoperative pain, cortisol, the frequency of PCA button pressed, and dose of additional analgesics of the experimental group were significantly lower than the control group. There were no statistical differences in blood pressure, heart rate and $O_2$ saturation between the experimental group and control group. Conclusions: We concluded that administration of morphine and ketorolac at 1 hr prior to skin incision resulted in decreasing postoperative pain, but it didn't affect blood pressure, heart rate or $O_2$ saturation for 24 hr after abdominal surgery.

유아 두개골 방사선촬영에서 피폭선량 감쇄에 관한 연구 (A Study on Dose Reduction in Infant Skull Radiography)

  • 안병주
    • 한국방사선학회논문지
    • /
    • 제11권5호
    • /
    • pp.387-392
    • /
    • 2017
  • 영 유아는 사건, 사고 및 교통사고 또는 질병으로 인해 머리에 골절 및 혈관파열, 피부에 상처를 받아 병원에 내원하여 영상의학과에서 머리 검사인 전 후(Skull AP) 및 측면(Skull LAT) 촬영을 받게 된다. 머리검사에서 성인 머리(Skull) 촬영은 격자를 이용하여 촬영에 적용하면 방사선 2차선을 제거하여 영상의 대조도를 높인다. 그러나 방사선 노출조건 중 관전압을 8~10 kVp 높게 주어야 하며 환자피폭이 증가한다. 본 연구는 영 유아 머리촬영시 격자(grid)를 이용하지 않고 동등한 영상을 얻을 수 있다면 피폭선량 감소 및 Grid Cut off에 의한 아티팩트를 방지할 수 있어 연구해 보았다. 연구자는 방사선계측기 이용 방사선선량을 측정 하고 의료영상평가 방법 중에서 주관적 평가(ROC,receiver operationg characteristic)을 해 보았다. 결과에서 격자를 이용하지 않고 촬영하면 환자 피폭선량 감소와 영상 평가에서도 영 유아의 머리 촬영시 격자를 이용하지 않고 촬영을 하게 되면 머리 전 후촬영에서 0.019 mGy 와 측면촬영 0.02 mGy 피폭선량 감소가 있었고 영상평가에서도 4점을 높게 받았다. 결론으로 병원에 내원한 영 유아 머리촬영은 격자를 이용하지 않고 촬영하면 피폭 선량 감소 및 영상 아티팩트인 Grid Cut off을 방지 할 수 있고 엑스선관 수명이 연장되리라 사료된다.

Treatment of primary cutaneous anaplastic large cell lymphoma

  • Baik, Bong Soo;Lee, Wu Seop;Ji, So Young;Park, Ki Sung;Yang, Wan Suk;Kim, Sun Young
    • 대한두개안면성형외과학회지
    • /
    • 제20권3호
    • /
    • pp.207-211
    • /
    • 2019
  • Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a rare subtype of primary cutaneous lymphoma with a favorable prognosis. Primary cutaneous CD30+ lymphoproliferative disorders, which include C-ALCL and lymphomatoid papulosis, are the second most common group of cutaneous T-cell lymphomas. C-ALCL is comprised of large cells with anaplastic, pleomorphic, or immunoblastic cytomorphology, and indeed, more than 75% of the tumor cells express the CD30 antigen. C-ALCL clinically presents with solitary or localized reddish-brown nodules or tumors, and sometimes indurated papules, and they may be with ulceration covering with dark eschar. Multifocal lesions are seen in 20% of the patients. Extracutaneous dissemination, which mainly involves the regional lymph nodes, occurs in 10% of patients. A 69-year-old man noticed a mild elevated cutaneous lesion containing central ulceration covering with brownish black necrotic tissue on the right lower lip, and the lesion was surgically removed. After the first operation, another skin lesion was developed and the histological examination confirmed the diagnosis, C-ALCL. Eight specimens were excised during the 7-month follow-up period. The patient started the treatment with low-dose oral methotrexate (15 mg/wk) and there was no recurrence for 11 months.

Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report

  • Park, Young Joo;Woo, Hyun Young;Kim, Moon Bum;Ahn, Jihyun;Heo, Jeong
    • Journal of Yeungnam Medical Science
    • /
    • 제39권3호
    • /
    • pp.256-261
    • /
    • 2022
  • Sarcoidosis often involves the liver. However, primary hepatic sarcoidosis confined to the liver without evidence of systemic involvement is rare. We report the case of a 37-year-old man with hepatic sarcoidosis who initially presented with elevated liver enzymes and suspicious cirrhotic nodules on computed tomography. The patient had cirrhosis but did not have portal hypertension. Based on the initial histopathologic finding of chronic granulomatous inflammation and the common clinical characteristics of sarcoidosis, he was initially diagnosed with primary biliary cholangitis, and his daily dosage of ursodeoxycholic acid was increased to 900 mg. After 14 months of treatment, his total serum bilirubin concentration was 10.9 mg/dL (upper normal limit, 1.2 mg/dL). Additionally, a transjugular liver biopsy revealed multiple noncaseating granulomas. He was diagnosed with primary hepatic sarcoidosis involving the lungs, heart, spleen, kidneys, and skin. Treatment with methylprednisolone was initiated. Two weeks later, he was started on azathioprine, and the dose of steroid was simultaneously reduced. These findings indicate the importance of including hepatic sarcoidosis as a possible diagnosis in patients with elevated liver enzymes or cryptogenic cirrhosis.

Fibular flap for mandible reconstruction in osteoradionecrosis of the jaw: selection criteria of fibula flap

  • Kim, Ji-Wan;Hwang, Jong-Hyun;Ahn, Kang-Min
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제38권
    • /
    • pp.46.1-46.7
    • /
    • 2016
  • Background: Osteoradionecrosis is the most dreadful complication after head and neck irradiation. Orocutaneous fistula makes patients difficult to eat food. Fibular free flap is the choice of the flap for mandibular reconstruction. Osteocutaneous flap can reconstruct both hard and soft tissues simultaneously. This study was to investigate the success rate and results of the free fibular flap for osteoradionecrosis of the mandible and which side of the flap should be harvested for better reconstruction. Methods: A total of eight consecutive patients who underwent fibula reconstruction due to jaw necrosis from March 2008 to December 2015 were included in this study. Patients were classified according to stages, primary sites, radiation dose, survival, and quality of life. Results: Five male and three female patients underwent operation. The mean age of the patients was 60.1 years old. Two male patients died of recurred disease of oral squamous cell carcinoma. The mean dose of radiation was 70.5 Gy. All fibular free flaps were survived. Five patients could eat normal diet after operation; however, three patients could eat only soft diet due to loss of teeth. Five patients reported no change of speech after operation, two reported worse speech ability, and one patient reported improved speech after operation. The ipsilateral side of the fibular flap was used when intraoral soft tissue defect with proximal side of the vascular pedicle is required. The contralateral side of the fibular flap was used when extraoral skin defect with proximal side of the vascular pedicle is required. Conclusions: Osteonecrosis of the jaw is hard to treat because of poor healing process and lack of vascularity. Free fibular flap is the choice of the surgery for jaw bone reconstruction and soft tissue fistula repair. The design and selection of the right or left fibular is dependent on the available vascular pedicle and soft tissue defect sites.

Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan

  • Khader, Jamal K.;Al-Mousa, Abdelatif M.;Mohamad, Issa A.;Abuhijlih, Ramiz A.;Al-Khatib, Sondos A.;Alnsour, Anoud Z.;Asha, Wafa A.;Ramahi, Shada W.;Hosni, Ali A.;Abuhijla, Fawzi J.
    • Radiation Oncology Journal
    • /
    • 제37권1호
    • /
    • pp.60-65
    • /
    • 2019
  • Purpose: The quality assurance (QA) chart rounds are multidisciplinary meetings to review radiation therapy (RT) treatment plans. This study focus on describing the changes in RT management based on QA round reviews in a single institution. Materials and Methods: After 9 full years of implementation, a retrospective review of all patients whose charts passed through departmental QA chart rounds from 2007 to 2015. The reviewed cases were presented for RT plan review; subcategorized based on decision in QA rounds into: approved, minor modifications or major modifications. Major modification defined as any substantial change which required patient re-simulation or re-planning prior to commencement of RT. Minor modification included treatment plan changes which didn't necessarily require RT re-planning. Results: Overall 7,149 RT treatment plans for different anatomical sites were reviewed at QA rounds. From these treatment plans, 6,654 (93%) were approved, 144 (2%) required minor modifications, while 351 (5%) required major modifications. Major modification included changes in: selected RT dose (96/351, 27%), target volume definition (127/351, 36%), organs-at-risk contouring (10/351, 3%), dose volume objectives/constraints criteria (90/351, 26%), and intent of treatment (28/351, 8%). The RT plans which required major modification according to the tumor subtype were as follows: head and neck (104/904, 12%), thoracic (12/199, 6%), gastrointestinal (33/687,5%), skin (5/106, 5%), genitourinary (16/359, 4%), breast (104/2387, 4%), central nervous system (36/846, 4%), sarcoma (11/277, 4%), pediatric (7/251, 3%), lymphoma (10/423, 2%), gynecological tumors (2/359, 1%), and others (11/351, 3%). Conclusion: Multi-disciplinary standardized QA chart rounds provide a comprehensive and an influential method on RT plans and/or treatment decisions.

Proposed Institutional Diagnostic Reference Levels in Computed and Direct Digital Radiography Examinations in Two Teaching Hospitals

  • Emmanuel Gyan;George Amoako;Stephen Inkoom;Christiana Subaar;Barry Rahman Maamah
    • Journal of Radiation Protection and Research
    • /
    • 제48권1호
    • /
    • pp.9-14
    • /
    • 2023
  • Background: The detectors of both computed radiography (CR) and direct digital radiography (DR) have a wide dynamic range that could tolerate high values of exposure factors without an adverse effect on image quality. Therefore, this study aims to assess patient radiation dose and proposes institutional diagnostic reference levels (DRLs) for two teaching hospitals in Ghana. Materials and Methods: CR and DR systems were utilized in this study from two teaching hospitals. The CR system was manufactured by Philips Medical Systems DMC GmbH, while the DR system was manufactured by General Electric. The entrance skin doses (ESDs) were calculated using the standard equation and the tube output measurements. Free-in-air kerma (µGy) was measured using a calibrated radiation dosimeter. The proposed institutional DRLs were estimated using 75th percentiles values of the estimated ESDs for nine radiographic projections. Results and Discussion: The calculated DRLs were 0.4, 1.6, 3.4, 0.5, 0.4, 1.1, 1.0, 1.2, and 1.7 mGy for chest posteroanterior (PA), lumbar spine anteroposterior (AP), lumbar spine lateral (LAT), cervical spine AP, cervical spine LAT, skull PA, pelvis AP, and abdomen AP, respectively in CR system. In the DR system, the values were 0.3, 1.6, 3.1, 0.4, 0.3, 0.7, 0.6, 0.9, and 1.3 for chest PA, lumbar spine AP, lumbar spine LAT, cervical spine AP, cervical spine LAT, skull PA, pelvis AP, and abdomen AP, respectively. Conclusion: Institutional DRLs in nine radiographic projections have been proposed for two teaching hospitals in Ghana for the first time. The proposed DRLs will serve as baseline data for establishing local DRLs in the hospitals and will be a valuable tool in optimizing patient doses.

유방암 환자의 수술 중 방사선치료 시 피부선량 측정을 통한 안전성 평가 (Evaluation of safety by skin dosimetry in Intraoperative Radiotherapy for breast cancer patients)

  • 정인호;김준원;박광우;하진숙;전미진;조윤진;김세준;김종대;신동봉
    • 대한방사선치료학회지
    • /
    • 제27권1호
    • /
    • pp.13-22
    • /
    • 2015
  • 목 적 : 유방암 환자를 대상으로 Intrabeam$^{TM}$ system을 이용한 수술 중 방사선치료(Intraoperative Radiotheray, IORT)를 국내에 처음 도입하는데 있어 광자극형광선량계(Optically Stimulated Luminescent Dosimeter, OSLD)를 이용한 피부선량측정을 통해 Intrabeam$^{TM}$ system의 안정성을 평가하고자 한다. 대상 및 방법 : 본원에서 2014년 8월부터 2015년 2월까지 유방보존술(breast-conserving surgery, BCS)후 Intrabeam$^{TM}$ system을 이용하여 수술 중 방사선치료(IORT)를 시행한 30명의 유방암 환자를 대상으로 진행하였다. 처방선량은 applicator 표면을 기준으로 20 Gy로 설정하여 1 cm 떨어진 지점에 약 5 Gy의 선량이 전달될 수 있도록 하였다. 종양 크기에 따라 applicator의 크기를 결정하였고 치료시간은 applicator의 크기에 따라 18~40분으로 설정되었다. 피부 절개면에서 Superior, Inferior, Lateral, Medial 4방향에 applicator를 중심으로부터 0.5 cm와 1.5 cm지점에 광자극형광선량계(OSLD)를 각각 부착하였다. 각 방향에 따라 U1,U2(Superior), D1,D2(Inferior), L1,L2(Lateral), M1,M2(Medial)로 총 8지점을 지정하였다. 각 지점에서의 측정값과 모든 지점의 평균값 및 최고값, 최저값을 산출하여 비교분석 하였다. 결 과 : Intrabeam$^{TM}$ system 50kVp X-ray source를 이용한 수술 중 방사선치료(IORT)시 OSLD의 측정 결과 U1 $2.23{\pm}0.80Gy$, U2 $1.54{\pm}0.53Gy$, D1 $1.73{\pm}0.63Gy$, D2 $1.25{\pm}0.45Gy$, L1 $1.95{\pm}0.82Gy$, L2 $1.38{\pm}0.42Gy$, M1 $2.03{\pm}0.70Gy$, M2 $1.51{\pm}0.58Gy$로 나타났으며 maximum값은 U1지점에서 4.34 Gy, minimum값은 M2지점에서 0.45 Gy로 나타났다. 전체 환자 중 13.3 %(N=4/30) 환자에서 4 Gy를 초과하는 측정값이 나타나 그 원인을 분석하였다. 결 론 : 본 연구를 통해 현재 본원에서 도입한 Intrabeam$^{TM}$ system을 이용한 수술 중 방사선치료(IORT)는 모든 환자의 피부선량값이 5 Gy미만으로 측정된 것으로 보아 그 안전성이 확인되었다. 피부선량이 4 Gy를 초과한 환자의 데이터 분석을 통해 breast volume이 상대적으로 작은 사이즈의 유방암환자의 경우 피부선량이 증가하는 경향을 보여 수술 중 방사선 치료 대상 환자 선정시 종양의 크기와 위치 뿐만 아닌 breast volume 값 등을 고려하여 피부에 전달되는 선량값이 기준값을 초과하지 않도록 주의 하여야 한다.

  • PDF

두경부 환자의 VMAT 시 체형변화와 환자 정렬과의 상관관계 고찰 (Evaluate the Change of Body Shape and the Patient Alignment State During Image-Guided Volumetric Modulated Arc Therapy in Head and Neck Cancer Patients)

  • 서세정;김태우;최민호;손종기
    • 대한방사선치료학회지
    • /
    • 제29권2호
    • /
    • pp.109-117
    • /
    • 2017
  • 목 적: 두경부 환자가 입체적 세기변조 회전 방사선치료 시 변화하는 체형과 환자 정열 상태를 조사하고 그에 따라 치료 시 발생하는 선량분포의 변화와 적절한 재 CT 모의치료의 필요성을 평가하고자 한다. 대상 및 방법: 근치적 목적으로 방사선 치료를 시행한 두경부암 89명에 대해 입체적 세기변조 방사선치료계획을 수립하고 치료 기간 동안의 체중을 측정하였다. 그 중 10명의 환자에 대하여 체형변화를 평가하였다. ARIA software(Offline review)를 이용하여 ramus, chin, posterior neck, clavicle 등의 landmark를 지정한 후 skin까지의 거리를 측정하여 차이를 분석하였다. 결 과: 남성 60명을 대상으로 치료시행 $17{\pm}4$회에서 re-CT 모의치료를 시행한 결과 체중 감소율이 $-6.47{\pm}3.5%$로 나타났으며, 여성 29명은 경우는 $17{\pm}5$회에서 체중 감소율이 $-5.73{\pm}2.7%$로 나타났다. 피부위축(Skin shrinkage) 변화를 관찰한 결과 대표 landmark에서의 표준편차는 C1(${\pm}0.44cm$), C3(${\pm}0.83cm$), C5(${\pm}1.35cm$)로서 0.5 kg 감소 당 약 1 mm shrinkage 발생함을 알 수 있었다. 치료 횟수에 따른 피부위축은 1~4 fx (변화 없음), 5~13 fx (-2 mm), 14~22 fx(-4 mm), 23~30 fx(-6 mm)로 나타났다. 결 론: 체형이 약 5 mm 변화하게 되면 중심부 선량은 약 3 % 이상 차이나기 시작하게 되므로 적응증치료에 필요한 CT 모의치료를 추가로 진행하여야만 한다. 또한 적극적으로 lower neck의 CT 모의치료 방법 및 set up 방법에 관하여 연구하고 새로운 고정용구(Immobilization device)의 사용도 검토할 필요가 있다.

  • PDF